Sturm, Ruger & Company (RGR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
10 Mar, 2026Executive summary
Beretta Holding S.A. sought to nominate four directors to the board at the 2026 annual meeting, following failed negotiations for increased ownership and board influence.
Beretta attempted to acquire Ruger stock at a 15% discount and demanded disproportionate board representation and voting power.
Ruger’s board rejected Beretta’s demands, citing concerns over shareholder dilution, governance, antitrust, and national security.
Ruger issued a press release to clarify its position and actions in response to Beretta’s public statements.
The board remains committed to protecting all stakeholders and maintaining independence.
Voting matters and shareholder proposals
Beretta formally notified its intent to nominate four candidates for election to the board at the 2026 annual meeting.
Ruger is reviewing Beretta’s nomination notice in accordance with established procedures and law.
Ruger will file a proxy statement and solicit proxies for the 2026 annual meeting.
Board of directors and corporate governance
Ruger refreshed its board by appointing three new directors in February 2026, following three retirements.
Five directors have joined the board in the past year, reflecting a proactive approach to governance.
The board’s refreshment process began before Beretta’s investment and was delayed to facilitate negotiations.
Ruger’s board rejected Beretta’s demands for board seats and governance rights that would violate best practices and laws.
Latest events from Sturm, Ruger & Company
- Board refresh and Ruger 2030 strategy drive strong returns and disciplined growth.RGR
Proxy filing24 Mar 2026 - Beretta’s bid for board control prompts defensive measures and governance refreshment.RGR
Proxy Filing9 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Sales growth and innovation offset market declines, but profitability fell year-over-year.RGR
Q4 20252 Mar 2026 - Q2 sales and profit declined, but new products and efficiency gains support future growth.RGR
Q2 20242 Feb 2026 - Q3 2024 sales rose 1.2% to $122.3M, but EPS and net income declined on margin pressure.RGR
Q3 202417 Jan 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Q4 sales and earnings rebounded on new product strength and market share gains.RGR
Q4 202423 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025